Document:

Exhibit
4.11

 

NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR
TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THIS SECURITY AND THE SECURITIES ISSUABLE UPON
EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

 

COMMON
STOCK PURCHASE WARRANT

 

CURATIVE
BIOTECHNOLOGY, Inc.

 

	Warrant
Shares: 5,000,000 	Initial Exercise Date: June 11, 2021

 

 

THIS
COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Paul Michaels (the “Holder”)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the five year anniversary
of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Curative
Biotechnology, Inc., a Florida corporation (the “Company”), up to 5,000,000 shares (the “Warrant Shares”)
of common stock of the Company (“Common Stock”). The purchase price of one share of Common Stock under this Warrant
shall be equal to the Exercise Price, as defined in Section 2(b).

 

    	1

    	 

    

 

Section
1. Exercise.

 

a)
Exercise of Warrant. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company (or such other office
or agency of the Company as it may designate by notice in writing to the registered Holder at the address of the Holder appearing on
the books of the Company) of a duly executed facsimile copy of the Notice of Exercise Form annexed hereto; and, within 3 “Business
Days” (weekdays on which banks are open for general banking business in New York City, New York) of the date said Notice of Exercise
is delivered to the Company, the Company shall have received payment of the aggregate Exercise Price of the shares thereby purchased
by wire transfer or cashier’s check drawn on a United States bank. Notwithstanding anything herein to the contrary, the Holder
shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available
hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation
within 3 Business Days of the date the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting
in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding
number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and
the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver
any objection to any Notice of Exercise Form within 1 Business Day of receipt of such notice. In the event of any dispute or discrepancy,
the records of the Company shall be controlling and determinative in the absence of manifest error. The Holder and any assignee, by
acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion
of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the
amount stated on the face hereof.

 

b)
Exercise Price. The exercise price per share of the Common Stock under this Warrant shall be $0.20, subject to adjustment
hereunder (the “Exercise Price”).

 

c)
Reserved.

 

    	2

    	 

    

 

d)
Exercise Limitations. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 21 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder’s Affiliates (defined as any person or
entity that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with
a Person, as such terms are used in and construed under Rule 405 under the Securities Act), and any other person or entity acting as
a group together with the Holder or any of the Holder’s Affiliates), would beneficially own in excess of the Beneficial Ownership
Limitation (as defined below). For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the
Holder and its Affiliates shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which
such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (A) exercise of
the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates and (B) exercise or conversion
of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock
Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the
Holder or any of its affiliates. Except as set forth in the preceding sentence, for purposes of this Section 1(d), beneficial ownership
shall be calculated in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended (“Exchange Act”)
and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the
Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules
required to be filed in accordance therewith. To the extent that the limitation contained in this Section 1(d) applies, the determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates) and of which
portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall
be deemed to be the Holder’s determination of whether this Warrant is exercisable (in relation to other securities owned by the
Holder together with any Affiliates) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership
Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination
as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and
regulations promulgated thereunder. For purposes of this Section 1(d), in determining the number of outstanding shares of Common Stock,
a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company’s Securities Exchange Commission
most recent filings or current public information from the OTC Markets website (C) a more recent public announcement by the Company or
(D) any other notice by the Company or the transfer agent of the Company setting forth the number of shares of Common Stock outstanding.
Upon the written or oral request of a Holder, the Company shall within five Business Days confirm orally and in writing to the Holder
the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined
after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates
since the date as of which such number of outstanding shares of Common Stock was reported. The “Beneficial Ownership Limitation”
shall be 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common
Stock issuable upon exercise of this Warrant. The Holder, upon not less than 61 days’ prior notice to the Company, may increase
or decrease the Beneficial Ownership Limitation provisions of this Section 1(d), provided that the Beneficial Ownership Limitation in
no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares
of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(d) shall continue to apply. Any
such increase or decrease will not be effective until the 61st day after such notice is delivered to the Company. The provisions
of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 1(d)
to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation
herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations
contained in this paragraph shall apply to a successor holder of this Warrant.

 

    	3

    	 

    

 

e)
Mechanics of Exercise.

 

i.
Delivery of Certificates Upon Exercise. Certificates for shares purchased hereunder shall be transmitted by the transfer agent
of the Company to the Holder by crediting the account of the Holder’s prime broker with the Depository Trust Company through its
Deposit Withdrawal Agent Commission (“DWAC”) system if the Company is then a participant in such system and either
(A) there is an effective registration statement permitting the resale of the Warrant Shares by the Holder or (B) the shares are eligible
for resale without volume or manner-of-sale limitations pursuant to Rule 144 (defined as Rule 144 promulgated by the Securities and Exchange
Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation
hereafter adopted by the Securities Exchange Commission having substantially the same purpose and effect as such Rule), and otherwise
by physical delivery to the address specified by the Holder in the Notice of Exercise within 5 Business Days from the delivery to the
Company of the Notice of Exercise Form, surrender of this Warrant (if required) and payment of the aggregate Exercise Price as set forth
above (the “Warrant Share Delivery Date”). This Warrant shall be deemed to have been exercised on the date the Exercise
Price is received by the Company. The Warrant Shares shall be deemed to have been issued, and Holder or any other person so designated
to be named therein shall be deemed to have become a holder of record of such shares for all purposes, as of the date the Warrant has
been exercised by payment to the Company of the Exercise Price and all taxes required to be paid by the Holder, if any, pursuant to Section
1(e)(v) prior to the issuance of such shares, have been paid.

 

ii.
Delivery of New Warrants Upon Exercise. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the certificate or certificates representing Warrant
Shares, deliver to Holder a new Warrant evidencing the rights of Holder to purchase the unpurchased Warrant Shares called for by this
Warrant, which new Warrant shall in all other respects be identical with this Warrant.

 

iii.
Rescission Rights. If the Company fails to cause the transfer agent of the Company to transmit to the Holder a certificate or
the certificates representing the Warrant Shares pursuant to Section 1(e)(i) by the Warrant Share Delivery Date, then, the Holder will
have the right to rescind such exercise.

 

iv.
No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.

 

    	4

    	 

    

 

v.
Charges, Taxes and Expenses. Issuance of certificates for Warrant Shares shall be made without charge to the Holder for any issue
or transfer tax or other incidental expense in respect of the issuance of such certificate, all of which taxes and expenses shall be
paid by the Company, and such certificates shall be issued in the name of the Holder or in such name or names as may be directed by the
Holder; provided, however, that in the event certificates for Warrant Shares are to be issued in a name other than the
name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed
by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax
incidental thereto.

 

vi.
Closing of Books. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.

 

Section
2. Adjustments for 

 

a)
Stock Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
make a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares or (iv) issues by reclassification of shares of the Common
Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the
numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 2(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.

 

b)
Reserved.

 

c)
Calculations. All calculations under this Section 2 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 2, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.

 

d)
Notice to Holder.

 

i.
Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 2, the Company
shall notify the Holder of the Exercise Price after such adjustment and setting forth a brief statement of the facts requiring such adjustment.
In the event the Company makes a public disclosure with regard to the adjustment, such public disclosure shall be deemed notice to the
Holder.

 

    	5

    	 

    

 

ii.
Notice to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or
substantially all of the assets of the Company, of any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be mailed to the Holder at its last address as it shall appear upon the
Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter specified, a
notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants,
or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions,
redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer
or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock
of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such
reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to mail such notice or any defect
therein or in the mailing thereof shall not affect the validity of the corporate action required to be specified in such notice. The
Holder is entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event
triggering such notice.

 

Section
3. Transfer of Warrant.

 

a)
Transferability. Subject to compliance with any applicable securities laws and the conditions set forth in Section 3(d) hereof,
this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part,
upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of
this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay
any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute
and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not
so assigned, and this Warrant shall promptly be cancelled. The Warrant, if properly assigned, may be exercised by a new holder for the
purchase of Warrant Shares without having a new Warrant issued.

 

    	6

    	 

    

 

b)
New Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 3(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the original Issue Date and
shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.

 

c)
Warrant Register. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
“Warrant Register”), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.

 

d)
Transfer Restrictions. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer
of this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under
applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions pursuant to Rule
144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of this Warrant, as the case may
be, may be required by the Company to provide an opinion of counsel with regard to such assignment or transfer.

 

Section
4. Miscellaneous.

 

a)
No Rights as Stockholder Until Exercise. This Warrant does not entitle the Holder to any voting rights or other rights as a stockholder
of the Company prior to the exercise hereof as set forth in Section 1(e)(i).

 

b)
Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.

 

    	7

    	 

    

 

c)
Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then, such action may be taken or such right may be exercised on the next succeeding Business
Day.

 

d)
Authorized Shares.

 

The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of executing stock certificates to execute and issue the necessary certificates for the Warrant Shares upon the exercise of
the purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant
Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading
Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise
of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant, be duly authorized,
validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue
thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).

 

Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.

 

Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.

 

    	8

    	 

    

 

e)
Jurisdiction. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed
by and construed and enforced in accordance with the internal laws of the State of Florida, without regard to the principles of conflict
of laws thereof. All legal proceedings concerning the interpretation, enforcement and defense of this Warrant (whether brought against
a party hereto or its respective affiliates, directors, officers, shareholders, employees or agents) shall be commenced in the state
and federal courts sitting in the County of Palm Beach, Florida (the “Palm Beach Courts”). Each party hereto
hereby irrevocably submits to the exclusive jurisdiction of the Palm Beach Courts the adjudication of any dispute hereunder or in connection
herewith or with any transaction contemplated hereby or discussed herein and hereby irrevocably waives, and agrees not to assert in any
suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of such Palm Beach Courts, or such Palm Beach
Courts are improper or inconvenient venue for such proceeding. EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED
BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS WARRANT OR THE TRANSACTIONS
CONTEMPLATED HEREBY.

 

f)
Restrictions. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, will
have restrictions upon resale imposed by state and federal securities laws.

 

g)
Nonwaiver and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice Holder’s rights, powers or remedies, notwithstanding the fact that all
rights hereunder terminate on the Termination Date. If the Company willfully and knowingly fails to comply with any provision of this
Warrant, which results in any material damages to the Holder, the Company shall pay to Holder such amounts as shall be sufficient to
cover any costs and expenses including, but not limited to, reasonable attorneys’ fees, including those of appellate proceedings,
incurred by Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.

 

    	9

    	 

    

 

h)
Notices. Any notice required or permitted hereunder shall be given in writing and shall be conclusively deemed effectively given
upon personal delivery or delivery by courier, or on the first Business Day after transmission if sent by confirmed facsimile transmission
or electronic mail (Email), or four (4) Business Days after deposit in the United States mail, by registered or certified mail, postage
prepaid, addressed to:

 

	 	If
    to Borrower, to:
	 	 	 
	 	 	Curative
    Biotechnology, Inc..
	 	 	Attn:
    I. Richard Garr, President
	 	 	1825
    NW Corporate Blvd.
	 	 	Boca
    Raton, FL 33431
	 	 	Email:
    irgarr@me.com
	 	 	 
	 	With
    a copy by Email only to (which copy shall not constitute notice):
	 	 	 
	 	 	Raul
    Silvestre
	 	 	Silvestre
    Law Group
	 	 	Email:
    rsilvestre@silvestrelaw.com
	 	 	 
	 	If
    to the Lender, to:
	 	 	 
	 	 	Name:
    Paul Michaels
	 	 	1825
    NW Corporate Blvd.
	 	 	Boca
    Raton, FL 33431
	 	 	Email:
    michaelspaul18@gmail.com

 

i)
Limitation of Liability. No provision hereof, in the absence of any affirmative action by Holder to exercise this Warrant to purchase
Warrant Shares, and no enumeration herein of the rights or privileges of Holder, shall give rise to any liability of Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.

 

j)
Remedies. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.

 

k)
Successors and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors of the Company and the successors and permitted assigns of Holder. The provisions
of this Warrant are intended to be for the benefit of all Holders from time to time of this Warrant and shall be enforceable by the Holder
or holder of Warrant Shares.

 

l)
Amendment. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Holder of the
Warrant.

 

m)
Severability. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.

 

n)
Headings. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.

 

********************

 (Signature
Pages Follow)

 

    	10

    	 

    

 

IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.

 

	 	CURATIVE BIOTECHNOLOGY, inc.
	 	By:	
	 	Name:	Barry
    Ginsberg
	 	Title:	Director

 

    	11

    	 

    

 

NOTICE
OF EXERCISE

 

To:
CURATIVE BIOTECHNOLOGY, inc.

 

(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

     

(2)
Payment shall take the form of (check applicable box):

     

[  ] in lawful money of the United States

     

(3)
Please issue a certificate or certificates representing said Warrant Shares in the name of the undersigned or in such other name as is
specified below:

_______________________________

 

The
Warrant Shares shall be delivered to the following DWAC Account Number or by physical delivery of a certificate to:

 

	 	_______________________________	 
	 	_______________________________	 
	 	_______________________________	 

 

 (4) Accredited Investor. The undersigned is an “accredited investor” as defined in Regulation D promulgated
under the Securities Act of 1933, as amended.

 

[SIGNATURE
OF HOLDER]

 

Name
of Investing Entity: ________________________________________________________________________

 

Signature
of Authorized Signatory of Investing Entity: _________________________________________________

 

Name
of Authorized Signatory: ___________________________________________________________________

 

Title
of Authorized Signatory: ____________________________________________________________________

 

Date:
________________________________________________________________________________________

 

    	12

    	 

    

 

ASSIGNMENT
FORM

 

(To
assign the foregoing warrant, execute

this form and supply required information.

Do not use this form to exercise the warrant.)

 

	FOR
    VALUE RECEIVED, [____] all of or [_______] shares of the foregoing Warrant and all rights evidenced thereby are hereby assigned to
	
	_______________________________________________
    whose address is
	_______________________________________________________________.
	 _______________________________________________________________
	 	Dated:
    ______________, _______
	 	 
	 	Holder’s
    Signature: _____________________________	 
	 	 	 
	 	Holder’s
    Address: _____________________________	 
	 	 	 
	Signature
    Guaranteed: ___________________________________________

 

NOTE:
The signature to this Assignment Form must correspond with the name as it appears on the face of the Warrant, without alteration or enlargement
or any change whatsoever, and must be guaranteed by a bank or trust company. Officers of corporations and those acting in a fiduciary
or other representative capacity should file proper evidence of authority to assign the foregoing Warrant.Exhibit 10.1

 

SUBSCRIPTION AGREEMENT

 

This SUBSCRIPTION AGREEMENT
(this “Subscription Agreement”) is entered into this day of August 12, 2022, by and among East Stone Acquisition
Corporation (“SPAC”), a British Virgin Islands business company, NWTN Inc., an exempted company incorporated
with limited liability in the Cayman Islands (“PubCo”), and the undersigned investor (“Subscriber”).
Capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed thereto in the Transaction Agreement
(as defined below).

 

WHEREAS, SPAC, ICONIQ Holding
Limited, an exempted company incorporated with limited liability in the Cayman Islands (the “Company”), PubCo, Navy
Sail International Limited, a British Virgin Islands Company, certain merger subsidiaries formed by PubCo and certain other party(ies)
thereto, have entered into a business combination transaction to the effect that upon consummation, both SPAC and the Company will become
wholly owned subsidiaries of PubCo on the terms and subject to the conditions set forth in the Business Combination Agreement dated as
of April 15, 2022 (as amended, modified, supplemented or waived from time to time in accordance with its terms, the “Transaction
Agreement”) (the “Transaction”);

 

WHEREAS, in connection
with the Transaction, Subscriber desires to subscribe for and purchase from PubCo, and PubCo desires to sell to Subscriber, that number
of ordinary shares of PubCo, which are entitled to one (1) vote per ordinary share (“PubCo Ordinary Shares”), set forth
on the signature page hereto for a purchase price of $10.26 per share or if lower, the Redemption Price (the “Per Share Price”
and the aggregate of such Per Share Price for all such ordinary shares subscribed for by Subscriber being referred to herein as the “Purchase
Price”), on the terms and subject to the conditions contained herein; and

 

WHEREAS, in connection
with the Transaction, certain other “qualified institutional buyers” (as defined in Rule 144A under the Securities Act
of 1933, as amended (the “Securities Act”)) and certain other institutional “accredited investors” (as
defined in Rule 501(a)(1), (2), (3) or (7) under the Securities Act) (each, an “Other Subscriber”) have entered
into or will enter into, severally and not jointly, separate subscription agreements with PubCo and SPAC (the “Other Subscription
Agreements”), pursuant to which such Other Subscribers have agreed or will agree to purchase PubCo Ordinary Shares at the same
Per Share Price as Subscriber.

 

NOW, THEREFORE, in consideration
of the foregoing and the mutual representations, warranties and covenants, and subject to the conditions, herein contained, and intending
to be legally bound hereby, the parties hereto hereby agree as follows:

 

1.                 
Subscription. Subject to the immediately succeeding paragraph, Subscriber hereby irrevocably subscribes for and agrees to
purchase from PubCo, and PubCo hereby agrees to issue and sell to Subscriber upon payment of the Purchase Price, such number of PubCo
Ordinary Shares as is set forth on the signature page of this Subscription Agreement (the “Shares”) on the terms and
subject to the conditions provided for herein (the “Subscription”).

 

2.                 
Closing. The closing of the Subscription contemplated hereby (the “Subscription Closing”) is contingent
upon the substantially concurrent consummation of the Transaction (the “Transaction Closing”). The Subscription Closing
shall occur on the date of, and immediately prior to or substantially concurrently with, the consummation of the Transaction Closing (the
“Transaction Closing Date”). Not less than five (5) business days prior to the scheduled Transaction Closing Date,
SPAC and PubCo shall provide written notice to Subscriber (the “Closing Notice”) (i) of such scheduled Transaction
Closing Date, (ii) that SPAC and PubCo reasonably expect all conditions to the closing of the Transaction to be satisfied or waived and
(iii) containing wire instructions for the payment of the Purchase Price. On the Transaction Closing Date specified in the Closing Notice,
the Purchase Price shall be delivered by wire transfer of United States dollars in immediately available funds to the account specified
by SPAC and PubCo in the Closing Notice. On the Transaction Closing Date, PubCo shall deliver to Subscriber (i) the Shares in book-entry
form, free and clear of any liens or other restrictions whatsoever (other than those arising under applicable securities laws or as set
forth herein), in the name of Subscriber (or its nominee in accordance with its delivery instructions) or to a custodian designated by
Subscriber, as applicable, and (ii) a copy of the records of PubCo’s transfer agent (the “Transfer Agent”) showing
Subscriber (or such nominee or custodian) as the owner of the Shares on and as of the Transaction Closing Date. For purposes of this Subscription
Agreement, “business day” shall mean any day other than Saturday, Sunday or such other days on which banks located in New
York, New York are required or authorized by applicable law to be closed for business.

  

If the Transaction Closing
does not occur on the same day as the Subscription Closing, PubCo shall promptly (but not later than one (1) business day thereafter)
return the Purchase Price to Subscriber by wire transfer of U.S. dollars in immediately available funds to the account specified by Subscriber,
and any book-entries shall be deemed cancelled.

 

     

     

    

 

Each book entry for the
Shares shall contain a notation, and each certificate (if any) evidencing the Shares shall be stamped or otherwise imprinted with a legend,
in substantially the following form:

 

THE SECURITIES REPRESENTED
HEREBY HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE OR OTHER
JURISDICTION, AND MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN EXEMPTION THEREFROM.

 

If this Subscription Agreement
terminates for any reason following the delivery by Subscriber of the Purchase Price for the Shares, PubCo shall promptly (but not later
than one (1) business day thereafter) return the Purchase Price to Subscriber by wire transfer of U.S. dollars in immediately available
funds to the account specified in writing by Subscriber, whether or not the Transaction Closing shall have occurred.

 

3.                 
Closing Conditions.

 

a.                  
The obligations of PubCo and SPAC to consummate the transactions contemplated hereunder are subject to the satisfaction (or waiver
by PubCo and SPAC in writing) of the conditions that, at the Subscription Closing:

 

		i	all representations and warranties of Subscriber contained in this Subscription Agreement shall be true
and correct in all material respects (other than representations and warranties that are qualified as to materiality, which representations
and warranties shall be true and correct in all respects) at and as of the Subscription Closing, and consummation of the Subscription
Closing shall constitute a reaffirmation by Subscriber of each of the representations, warranties and agreements of such party contained
in this Subscription Agreement as of the Subscription Closing; and

		ii	Subscriber shall have performed or complied in all material respects with all agreements and covenants
required by this Subscription Agreement required to be performed or complied with at or prior to the Subscription Closing.

 

b.                 
The obligations of Subscriber to consummate the transactions contemplated hereunder are subject to the satisfaction (or waiver
by Subscriber in writing) of the conditions that, at the Subscription Closing:

 

		i	all representations and warranties of PubCo and SPAC contained in this Subscription Agreement shall be
true and correct in all material respects (other than representations and warranties that are qualified as to materiality or Material
Adverse Effect (as defined herein), which representations and warranties shall be true and correct in all respects) at and as of the Subscription
Closing except to the extent that any such representation or warranty expressly is made as of an earlier date, in which case such representation
and warranty shall be true and correct as of such specified date, and consummation of the Subscription Closing shall constitute a reaffirmation
by PubCo and SPAC of each of the representations, warranties and agreements of such party contained in this Subscription Agreement as
of the Subscription Closing;

		ii	PubCo and SPAC each shall have performed or complied in all material respects with all of its respective
agreements and covenants required by this Subscription Agreement required to be performed or complied with at or prior to the Subscription
Closing;

		iii	the Shares shall have been approved for listing on the Nasdaq Stock Market (“Nasdaq”)
or the New York Stock Exchange (“NYSE”), as applicable, subject to official notice of issuance; and

		iv	other than the Other Subscription Agreements, SPAC and PubCo shall not have entered into any side letter
or similar agreement with any Other Subscriber, and there shall have been no amendment, waiver or modification to any Other Subscription
Agreement that materially benefits any Other Subscriber thereunder unless Subscriber has been offered the same benefits.

 

c.                  
The obligations of each of PubCo, SPAC and Subscriber to consummate the transactions contemplated hereunder are subject to the
satisfaction (or waiver by PubCo, SPAC and Subscriber in writing) of the conditions that, at the Subscription Closing:

 

		i	no applicable Governmental Authority (as defined herein) shall have enacted, issued, promulgated, enforced
or entered any judgment, order, law, rule or regulation (whether temporary, preliminary or permanent) which is then in effect and has
the effect of making consummation of the transactions contemplated hereby illegal or otherwise prohibiting consummation of the transactions
contemplated hereby, and no Governmental Authority shall have instituted or threatened in writing a proceeding seeking to impose any such
prohibition; and

		ii	all conditions precedent to the Transaction Closing, including the approval of SPAC’s stockholders,
shall have been satisfied or waived (other than those conditions which, by their nature, are to be satisfied at the Transaction Closing).

 

    2 

     

    

 

4.                 
IRS Form W-9; Further Assurances. Prior to the Subscription Closing, Subscriber shall provide SPAC and PubCo with a properly
completed and duly executed IRS Form W-9 or applicable IRS Form W-8, as appropriate. At or prior to the Subscription Closing, the parties
hereto shall execute and deliver such additional documents and take such additional actions as the parties reasonably may deem to be practical
and necessary in order to consummate the Subscription as contemplated by this Subscription Agreement.

 

5.                 
SPAC and PubCo Representations and Warranties. Each of SPAC and PubCo hereby represents and warrants to Subscriber that:

 

a.                  
Each of SPAC and PubCo is a company duly organized, validly existing and in good standing under the laws of the jurisdiction of
its respective incorporation or organization and has the requisite corporate or limited liability power and authority to own, lease and
operate its properties and to carry on its business as it is currently being conducted.

 

b.                 
The Shares have been duly authorized and, when issued and delivered to Subscriber against full payment therefor in accordance with
the terms of this Subscription Agreement and registered in PubCo’s register of members, the Shares will be validly issued, fully
paid and non-assessable, free and clear of any liens or other restrictions (other than those arising under applicable laws) and will not
have been issued in violation of or subject to any preemptive or similar rights under the memorandum and articles of association of PubCo
(together, and in each case as amended, modified or supplemented from time to time, the “PubCo Charter”) or under the
laws of the Cayman Islands.

 

c.                  
This Subscription Agreement has been duly authorized, executed and delivered by each of SPAC and PubCo and constitutes the legal,
valid and binding agreement of each of SPAC and PubCo, enforceable against SPAC and PubCo in accordance with its terms, except as may
be limited or otherwise affected by (i) bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or other laws relating
to or affecting the rights of creditors generally, and (ii) principles of equity, whether considered at law or equity.

 

d.                 
The execution, delivery and performance of this Subscription Agreement, the issuance and sale of the Shares and the compliance
by each of SPAC and PubCo with all of the provisions of this Subscription Agreement and the consummation of the transactions contemplated
hereby will not (i) conflict with or violate the SPAC certificate of incorporation and bylaws, in each case as amended, modified
or supplemented from time to time, or the PubCo Charter, (ii) assuming that all consents, approvals, authorizations, expiration or
termination of waiting periods and other actions described in Section 5(e) hereof have been obtained and all filings
and obligations described in Section 5(e) have been made, conflict with or violate any statute or any judgment, order, rule or
regulation of any court or governmental agency or body, domestic or foreign, having jurisdiction over SPAC or PubCo, or by which any of
their respective properties or assets is bound or affected, or (iii) result in any breach of, or constitute a default (or an event
which, with notice or lapse of time or both, would become a default) under, or give to others any rights of termination, amendment, acceleration
or cancellation of, or result in the creation of a lien on any property or asset of SPAC or PubCo pursuant to, any note, bond, mortgage,
indenture, contract, agreement, lease, license, permit, franchise or other instrument or obligation to which SPAC or PubCo is a party,
or by which SPAC or PubCo or any of their respective properties or assets is bound or affected, except, with respect to clauses (ii)
and (iii), for any such conflicts, violations, breaches, defaults or other occurrences which would not have or reasonably be expected
to have a material adverse effect on the business, properties, financial condition, assets and liabilities or results of operations of
SPAC or PubCo or materially affect the validity of the Shares or the legal authority of SPAC or PubCo to comply in all material respects
with the terms of this Subscription Agreement (a “Material Adverse Effect”).

 

e.                  
The issuance and sale of the Shares and the compliance by each of SPAC and PubCo with all of the provisions of this Subscription
Agreement and the consummation of the transactions contemplated hereby will not require any consent, approval, authorization or permit
of, or filing with or notification to, or expiration or termination of any waiting period by, any United States federal, state, county,
local or non-U.S. government, governmental, regulatory or administrative authority, agency, instrumentality or commission or any court,
tribunal, or judicial or arbitral body (a “Governmental Authority”), except (i) for applicable requirements, if
any, of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the Securities Act, state securities
or “blue sky” laws and state takeover laws, filings required by Nasdaq and/or the NYSE, and filing with and registration by
the Registrar of Companies of appropriate merger documents as required by the Companies Law (2020 Revision), as amended, of the Cayman
Islands and (ii) where the failure to obtain such consents, approvals, authorizations or permits, or to make such filings or notifications,
would not have or would not reasonably be expected to have a Material Adverse Effect or otherwise prevent SPAC or PubCo from performing
its material obligations under this Subscription Agreement.

 

f.                   
Each of SPAC and PubCo is in compliance with all applicable laws, except where such non-compliance would not reasonably be expected
to have a Material Adverse Effect.

 

g.                 
Upon the closing of the Transaction, the issued and outstanding PubCo Ordinary Shares will be registered pursuant to Section 12(b)
of the Exchange Act, and will be listed for trading on either Nasdaq or the NYSE. There is no suit, action, proceeding or investigation
pending or, to the knowledge of PubCo, threatened against PubCo by Nasdaq, the NYSE or the Securities and Exchange Commission (the “SEC”)
with respect to any intention by such entity to deregister the PubCo Ordinary Shares or prohibit or terminate the listing of the PubCo
Ordinary Shares on Nasdaq or the NYSE. PubCo has taken no action that is designed to prevent the registration of the PubCo Ordinary Shares
under the Exchange Act.

 

h.                 
Assuming the accuracy of Subscriber’s representations and warranties set forth in Section 6 of this Subscription
Agreement, no registration under the Securities Act is required for the offer and sale of the Shares by PubCo to Subscriber.

 

    3 

     

    

 

i.                   
As of their respective dates, all filings (the “SEC Documents”), if any, filed by each of PubCo and SPAC with
the SEC complied in all material respects with the applicable requirements of the Securities Act and the Exchange Act and the rules and
regulations of the SEC promulgated thereunder, and, to the knowledge of Pubco and SPAC, none of the SEC Documents, when filed (or, if
amended, as of the date of such amendment), contained any untrue statement of a material fact or omitted to state a material fact required
to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made,
not misleading. A copy of each SEC Document is available to each Subscriber via the SEC’s EDGAR system. Except for comments on the
Form S-4 filed with the SEC by SPAC on June 28, 2021 (as amended) in relation to the prior business combination with JHD Technologies
Limited, there are no material outstanding or unresolved comments in comment letters received by SPAC or PubCo from the staff of the Division
of Corporation Finance (the “Staff”) of the SEC with respect to any of the SEC Documents.

 

j.                   
The authorized capital stock of SPAC consists of an unlimited number of shares of SPAC’s ordinary shares, no par value per
share, (“SPAC Ordinary Shares”) and an unlimited number of preferred shares, no par value (“SPAC Preferred
Shares”). As of the date of this Subscription Agreement, (i)7,174,245 SPAC Ordinary Shares are issued and outstanding, all of
which are validly issued, fully paid and non-assessable and not subject to any preemptive rights, (ii) no SPAC Preferred Shares are issued
and outstanding, (iii) 3,264,744 SPAC Ordinary Shares are held in the treasury of SPAC, (iv) 350,000 private placement warrants (the “Private
Placement Warrants”) are issued and outstanding and 175,000 SPAC Ordinary Shares are issuable in respect of such Private Placement
Warrants, (v) 690,000 underwriter warrants (the “Underwriter Warrants”) are issued and outstanding and 345,000 SPAC
Ordinary Shares are issuable in respect of such Underwriter Warrants, (vi) 13,800,000 public warrants (the “Public Warrants”)
are issued and outstanding and 6,900,000 SPAC Ordinary Shares are issuable in respect of such Public Warrants, (vii) 14,150,000 rights,
exchangeable into one-tenth of one SPAC Ordinary Share to purchase (the “SPAC Rights”) are issued and outstanding and
1,415,000 SPAC Ordinary Shares are issuable in respect of such SPAC Rights. Each Private Placement Warrant, Underwriter Warrant and Public
Warrant is exercisable for one-half of one SPAC Ordinary Share at an exercise price of $11.50. Except as set forth above and pursuant
to the Other Subscription Agreements, the Transaction Agreement and the other agreements and arrangements referred to therein or in the
SEC Documents, as of the date of this Subscription Agreement, there are no outstanding options, warrants or other rights to subscribe
for, purchase or acquire from SPAC any SPAC Common Stock or other equity interests in SPAC, or securities convertible into or exchangeable
or exercisable for such equity interests. There are no securities issued by SPAC or instruments to which SPAC is a party containing anti-dilution
or similar provisions that will be triggered by the transactions contemplated by the Transaction Agreement or the issuance of the Shares
pursuant to this Subscription Agreement or PubCo Ordinary Shares issued pursuant to the Other Subscription Agreements that have not been
or will not be validly waived on or prior to the closing of the Transaction.

 

k.                 
As of the date of this Subscription Agreement, the authorized share capital of PubCo consists of 500,000,000 ordinary shares of
PubCo, par value $0.0001 per share, of which one (1) Pubco ordinary share is issued and outstanding, and owned by the Company. All outstanding
ordinary shares of PubCo are duly authorized, validly issued, fully paid and non-assessable, are not subject to preemptive rights and
are held free and clear of all liens, other than transfer restrictions under applicable securities laws and the PubCo Charter. Except
as set forth above and pursuant to the Other Subscription Agreements, the Transaction Agreement and the other agreements and arrangements
referred to therein or in the SEC Documents, as of the date of this Subscription Agreement, there are no outstanding options, warrants
or other rights to subscribe for, purchase or acquire from PubCo any ordinary shares of PubCo or other equity interests in PubCo, or securities
convertible into or exchangeable or exercisable for such equity interests. As of the date of this Subscription Agreement, there are no
securities issued by PubCo or instruments to which PubCo is a party containing anti-dilution or similar provisions that will be triggered
by the transactions contemplated by the Transaction Agreement or the issuance of the Shares pursuant to this Subscription Agreement or
PubCo Ordinary Shares issued pursuant to the Other Subscription Agreements that have not been or will not be validly waived on or prior
to the closing of the Transaction.

 

l.                   
Except for such matters as have not had and would not be reasonably likely to have a Material Adverse Effect, there is no (i) action,
suit or claim,, in each case by any Governmental Authority , or, to the knowledge of SPAC or PubCo, threatened against SPAC or PubCo or
(ii) judgment, decree, injunction or ruling of any governmental entity or arbitrator outstanding against SPAC or PubCo.

 

m.               
Other than the Other Subscription Agreements, neither SPAC nor PubCo has entered into any side letter or similar agreement with
any Other Subscriber in connection with such Other Subscriber’s direct or indirect investment in PubCo, and such Other Subscription
Agreements have not been amended in any material respect following the date of this Subscription Agreement and reflect the same Per Share
Price and terms that are no more favorable to such Other Subscribers thereunder than the terms of this Subscription Agreement.

 

n.                 
Neither PubCo nor any person acting on its behalf has engaged or will engage in any form of general solicitation or general advertising
(within the meaning of Regulation D of the Securities Act) in connection with any offer or sale of the Shares.

  

o.                 
In light of the “Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition
Companies” issued by the Staff on April 12, 2021 and related guidance by the SEC, notwithstanding anything to the contrary contained
in this Section 5 of this Subscription Agreement, no representation or warranty is made by SPAC as to the historical accounting
treatment of the Public Warrants and Private Placement Warrants; any deficiencies in disclosure (including with respect to financial statement
presentation or accounting and disclosure controls) arising from the treatment of the Public Warrants and Private Placement Warrants as
equity rather than liabilities in SPAC’s historical financial statements and SEC Documents; or any changes that may be required
to SPAC’s historical financial statements and SEC Documents, including any required restatements of SEC Documents or of any financial
statements contained therein.

 

    4 

     

    

 

6.                 
Subscriber Representations and Warranties. Subscriber hereby represents and warrants to SPAC and PubCo that:

 

a.                  
Subscriber is (i) a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act) or (ii) an institutional
“accredited investor” (within the meaning of Rule 501(a)(1), (2), (3) or (7) under the Securities Act), in each case,
satisfying the requirements set forth on Schedule A hereto, and is acquiring the Shares only for its own account and not for
the account of others, and not on behalf of any other account or person or with a view to, or for offer or sale in connection with, any
distribution thereof in violation of the Securities Act (and shall provide the requested information on Schedule A hereto
following the signature page hereto). Accordingly, Subscriber understands that the offering of the Shares meets the exemptions from filing
under Financial Industry Regulatory Authority, Inc. (“FINRA”) Rule 5123(b)(1)(C) or (J). Subscriber is not an
entity formed for the specific purpose of acquiring the Shares.

 

b.                 
Subscriber (i) is an institutional account as defined in FINRA Rule 4512(c), (ii) is a sophisticated investor, experienced
in investing in business and finance transactions and capable of evaluating investment risks independently, both in general and with regard
to all transactions and investment strategies involving a security or securities and (iii) has exercised independent judgment in evaluating
its participation in the purchase of the Shares. Accordingly, Subscriber understands that the offering meets (x) the exemptions from filing
under FINRA Rule 5123(b)(1)(A) and (y) the institutional customer exemption under FINRA Rule 2111(b).

 

c.                  
Subscriber understands that the Shares are being offered in a transaction not involving any public offering within the meaning
of the Securities Act and that the Shares have not been registered under the Securities Act. Subscriber understands that the Shares may
not be resold, transferred, pledged (other than pledges in the ordinary course of business as part of prime brokerage arrangements) or
otherwise disposed of by Subscriber absent an effective registration statement under the Securities Act, except (i) to PubCo or a subsidiary
thereof, (ii) to non-U.S. persons pursuant to offers and sales that occur outside the United States within the meaning of Regulation S
under the Securities Act or (iii) pursuant to another applicable exemption from the registration requirements of the Securities Act, and,
in each of cases (i) and (iii), in accordance with any applicable securities laws of the states and other jurisdictions of the United
States, and that any certificates or book-entry positions representing the Shares shall contain a legend to such effect. Subscriber acknowledges
that the Shares will not be eligible for resale pursuant to Rule 144A promulgated under the Securities Act. Subscriber understands
and agrees that the Shares will be subject to the foregoing transfer restrictions and, as a result of these transfer restrictions, Subscriber
may not be able to readily resell the Shares and may be required to bear the financial risk of an investment in the Shares for an indefinite
period of time. Subscriber understands that it has been advised to consult legal counsel prior to making any offer, resale, pledge or
transfer of any of the Shares.

 

d.                 
Subscriber understands and agrees that Subscriber is purchasing the Shares directly from PubCo. Subscriber further acknowledges
that there have been no representations, warranties, covenants and agreements made to Subscriber by SPAC, PubCo, the Company or any of
their respective officers or directors, or any other party to the Transaction or person or entity, expressly or by implication, other
than those representations, warranties, covenants and agreements included in this Subscription Agreement.

 

e.                  
Either (i) Subscriber is not a Benefit Plan Investor as contemplated by the Employee Retirement Income Security Act of 1974, as
amended (“ERISA”), or (ii) Subscriber’s acquisition and holding of the Shares will not constitute or result in
a non-exempt prohibited transaction under Section 406 of ERISA, Section 4975 of the Internal Revenue Code of 1986, as amended,
or any applicable similar law.

 

f.                   
Subscriber acknowledges and agrees that Subscriber has received and has had an adequate opportunity to review, such financial and
other information as Subscriber deems necessary in order to make an investment decision with respect to the Shares and made its own assessment
and is satisfied concerning the relevant tax and other economic considerations relevant to Subscriber’s investment in the Shares.
Without limiting the generality of the foregoing, Subscriber (for itself and, if applicable, for each account for which it is acquiring
the Shares) acknowledges that it has reviewed the documents provided to Subscriber by SPAC and PubCo. Subscriber (for itself and, if applicable,
for each account for which it is acquiring the Shares) represents and agrees that Subscriber and Subscriber’s professional advisor(s),
if any, have had the full opportunity to ask such questions and receive such answers from SPAC and PubCo or any person or persons acting
on their behalf concerning the terms and conditions of an investment in the Shares, have obtained such materials or information as Subscriber
and Subscriber’s professional advisor(s), if any, have deemed necessary to make an investment decision with respect to the Shares
and have independently made their own analysis and decision to invest in the Shares.

  

g.                 
Subscriber became aware of this offering of the Shares solely by means of direct contact between Subscriber, on the one hand, and
PubCo, SPAC and/or their respective representatives on behalf of SPAC as a result of a pre-existing substantive relationship, and the
Shares were offered to Subscriber solely by direct contact between Subscriber and PubCo or a representative of PubCo. Subscriber did not
become aware of this offering of the Shares, nor were the Shares offered to Subscriber, by any other means. Subscriber acknowledges that
PubCo represents and warrants that the Shares (i) were not offered by any form of general solicitation or general advertising and (ii)
are not being offered in a manner involving a public offering under, or in a distribution in violation of, the Securities Act, or any
state securities laws.

 

    5 

     

    

 

h.                 
Subscriber acknowledges that it is aware that there are substantial risks incident to the purchase and ownership of the Shares.
Subscriber is able to fend for himself, herself or itself in the transactions completed herein, has such knowledge and experience in financial
and business matters as to be capable of evaluating the merits and risks of an investment in the Shares and has the ability to bear the
economic risks of such investment in the Shares and can afford a complete loss of such investment. Subscriber has sought such accounting,
legal and tax advice as Subscriber has considered necessary to make an informed investment decision.

 

i.                   
Alone, or together with any professional advisor(s), Subscriber has analyzed and considered the risks of an investment in the Shares
and determined that the Shares are a suitable investment for Subscriber and that Subscriber is able at this time and in the foreseeable
future to bear the economic risk of a total loss of Subscriber’s investment in PubCo. Subscriber acknowledges specifically that
a possibility of total loss exists.

 

j.                   
In making its decision to purchase the Shares, Subscriber has relied solely upon independent investigation made by Subscriber and
the representations, warranties and covenants contained herein.

 

k.                 
Subscriber understands that no federal or state agency has passed upon or endorsed the merits of the offering of the Shares or
made any findings or determination as to the fairness of this investment.

 

l.                   
Subscriber has been duly formed or incorporated and is validly existing in good standing under the laws of its jurisdiction of
incorporation or formation.

 

m.               
The execution, delivery and performance by Subscriber of this Subscription Agreement are within the powers of Subscriber, have
been duly authorized and will not constitute or result in a breach or default under or conflict with any order, ruling or regulation of
any court or other tribunal or of any governmental commission or agency, or any agreement or other undertaking, to which Subscriber is
a party or by which Subscriber is bound, and will not violate any provisions of Subscriber’s organizational documents, including,
without limitation, its incorporation or formation papers, bylaws, indenture of trust or partnership or operating agreement, as may be
applicable. The signature on this Subscription Agreement is genuine, and the signatory has legal competence and capacity to execute the
same and has been duly authorized by Subscriber to execute the same on behalf of Subscriber, and this Subscription Agreement constitutes
a legal, valid and binding obligation of Subscriber, enforceable against Subscriber in accordance with its terms, except as may be limited
or otherwise affected by (i) bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or other laws relating to or affecting
the rights of creditors generally, and (ii) principles of equity, whether considered at law or equity.

 

n.                 
Neither the due diligence investigation conducted by Subscriber in connection with making its decision to acquire the Shares nor
any representations and warranties made by Subscriber herein shall modify, amend or affect Subscriber’s right to rely on the truth,
accuracy and completeness of SPAC’s and PubCo’s representations and warranties contained herein.

 

o.                 
Neither Subscriber nor any of its officers, directors, managers, managing members, general
partners or any other person acting in a similar capacity or carrying out a similar function is (i) a person or entity named on
the List of Specially Designated Nationals and Blocked Persons administered by the U.S. Treasury Department’s Office of Foreign
Assets Control (“OFAC”) or in any Executive Order issued by the President of the United States and administered by
OFAC or any similar list of sanctioned persons administered by the European Union or any individual European Union member state, including
the United Kingdom (collectively, “Sanctions Lists”),
or a person or entity prohibited by any OFAC sanctions program, (ii) directly or indirectly owned or controlled by, or acting on
behalf of, one or more persons on a Sanctions List; (iii) organized, incorporated, established, located, resident or born in, or
a citizen, national, or the government, including any political subdivision, agency, or instrumentality thereof, of, Cuba, Iran, North
Korea, Syria, Venezuela, the Crimea region of Ukraine, or any other country or territory embargoed or subject to substantial trade restrictions
by the United States, the European Union or any individual European Union member state, including the United Kingdom; (iv) a Designated
National as defined in the Cuban Assets Control Regulations, 31 C.F.R. Part 515, or (v) a non-U.S. shell bank or providing banking services
indirectly to a non-U.S. shell bank (collectively, a “Prohibited Investor”). Subscriber agrees to provide law enforcement
agencies, if requested thereby, such records as required by applicable law, provided that Subscriber is permitted to do so under
applicable law. If Subscriber is a financial institution subject to the Bank Secrecy Act (31 U.S.C. Section 5311 et seq.) (the “BSA”),
as amended by the USA PATRIOT Act of 2001 (the “PATRIOT Act”), and its implementing regulations (collectively, the
“BSA/PATRIOT Act”), Subscriber maintains policies and procedures reasonably designed to comply with applicable obligations
under the BSA/PATRIOT Act. To the extent required, it maintains policies and procedures reasonably designed to ensure compliance with
sanctions programs administered by OFAC, the European Union and any European Union member state, including the United Kingdom, including
for the screening of its investors against the Sanctions Lists and the OFAC sanctions programs. To the extent required, it maintains policies
and procedures reasonably designed to ensure that the funds held by Subscriber and used to purchase the Shares were legally derived and
were not obtained, directly or indirectly, from a Prohibited Investor.

  

p.                 
Subscriber has or has enforceable commitments to have, and at least two (2) business days prior to the Transaction Closing Date
will have, sufficient funds to pay the Purchase Price and consummate the Subscription Closing when required pursuant to this Subscription
Agreement.

 

q.                 
Subscriber acknowledges that no foreign person (as defined in 31 C.F.R. Part 800.224) in which the national or subnational governments
of a single foreign state have a substantial interest (as defined in 31 C.F.R. Part 800.244) will acquire a substantial interest in PubCo
as a result of the purchase and sale of Shares hereunder such that a declaration to the Committee on Foreign Investment in the United
States would be mandatory under 31 C.F.R. Part 800.401, and no foreign person will have control (as defined in 31 C.F.R. Part 800.208)
over PubCo from and after the Transaction Closing as a result of the purchase and sale of Shares hereunder.

 

    6 

     

    

 

7.                 
Registration Rights.

 

a.                  
PubCo agrees that, within 90 days after the Transaction Closing Date (the “Filing Deadline”), PubCo will file
with the SEC (at PubCo’s sole cost and expense) a registration statement (the “Registration Statement”) registering
under the Securities Act the resale of all the Shares, and PubCo shall use its commercially reasonable efforts to have the Registration
Statement declared effective as soon as practicable after the filing thereof, but no later than the earlier of (i) the 60th
calendar day (or 90th calendar day if the SEC notifies PubCo that it will “review” the Registration Statement)
following the Filing Deadline and (ii) the 10th business day after the date PubCo is notified (orally or in writing, whichever is earlier)
by the SEC that the Registration Statement will not be “reviewed” or will not be subject to further review (such earlier date,
the “Effectiveness Date”); provided, however, that PubCo’s obligations to include the Shares in
the Registration Statement are contingent upon Subscriber furnishing in writing to PubCo such information regarding Subscriber, the securities
of PubCo held by Subscriber and the intended method of disposition of the Shares as shall be reasonably requested by PubCo to effect the
registration of the Shares, and shall execute such documents in connection with such registration as PubCo may reasonably request that
are customary of a selling stockholder in similar situations, provided that Subscriber shall not in connection with the foregoing be required
to execute any lock-up or similar agreement or otherwise be subject to any contractual restriction on the ability to transfer the Shares.
In no event shall the Subscriber be identified as a statutory underwriter in the Registration Statement unless requested by the SEC and
consented to in writing by Subscriber; provided, that if the SEC requests that the Subscriber be identified as a statutory underwriter
in the Registration Statement, the Subscriber will have an opportunity to withdraw its Shares from the Registration Statement. Notwithstanding
the foregoing, if the SEC prevents PubCo from including any or all of the shares proposed to be registered under the Registration Statement
due to limitations on the use of Rule 415 of the Securities Act for the resale of the shares by the selling shareholders named therein
or otherwise, such Registration Statement shall register for resale such number of shares equal to the maximum number of shares as is
permitted by the SEC. In such event, the number of shares to be registered for each selling shareholder named in the Registration Statement
shall be reduced pro rata among all such selling shareholders and as promptly as practicable after being permitted to register additional
shares under Rule 415 under the Securities Act, PubCo shall file a new Registration Statement to register such shares not included in
the initial Registration Statement and cause such Registration Statement to become effective as promptly as practicable consistent with
the terms of this Section 7. For purposes of this Section 7, “Shares” shall mean, as of any date of determination,
the Shares acquired by the Subscriber pursuant to this Subscription Agreement and any other equity security issued or issuable with respect
to such Shares by way of stock split, dividend, distribution, recapitalization, merger, exchange, replacement or similar event, and “Subscriber”
shall include any person to whom rights under this Section 7 have been properly assigned in accordance with the terms of this Subscription
Agreement. PubCo shall use its commercially reasonable efforts to maintain the continuous effectiveness of the Registration Statement
until the earliest of (i) the date on which the Shares may be resold without volume or manner of sale limitations pursuant to Rule 144
promulgated under the Securities Act (“Rule 144”) and without the requirement for PubCo to be in compliance with the
current public information requirement under Rule 144, (ii) the date on which such Shares have actually been sold and (iii) the date which
is two years after the Subscription Closing (such date, the “End Date”). For purposes of clarification, any failure
by PubCo to file the Registration Statement by the Filing Deadline or to have such Registration Statement declared effective by the Effectiveness
Date shall not otherwise relieve PubCo of its obligations to file or effect the Registration Statement set forth in this Section 7.

 

b.                 
In the case of the registration, qualification, exemption or compliance effected by the PubCo pursuant to this Subscription Agreement,
PubCo shall, upon reasonable request, inform Subscriber as to the status of such registration, qualification, exemption and compliance.
PubCo shall, at its expense:

 

	 	(i)	until the End Date, advise the Subscriber as promptly as practicable: (A) when a Registration Statement or any post-effective amendment thereto has become effective; (B) of the issuance by the SEC of any stop order suspending the effectiveness of the Registration Statement or the initiation of any proceedings for such purpose; (C) of the receipt by PubCo of any notification with respect to the suspension of the qualification of the Shares included therein for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; and (D) subject to the applicable provisions of this Section 7, of the occurrence of any event that requires the making of any changes in the Registration Statement or prospectus so that, as of such date, the statements therein are not misleading and do not omit to state a material fact required to be stated therein or necessary to make the statements therein (in the case of a prospectus, in the light of the circumstances under which they were made) not misleading. Notwithstanding anything to the contrary set forth herein, PubCo shall not, when so advising Subscriber of such events, provide Subscriber with any material, nonpublic information regarding PubCo other than to the extent that providing notice to Subscriber of the occurrence of the events listed in (A) through (D) above constitutes material, nonpublic information regarding PubCo;
	 	(ii)	until the End Date, use its commercially reasonable efforts to obtain the withdrawal of any order suspending the effectiveness of the Registration Statement as promptly as reasonably practicable and to enable the undersigned to sell the Shares under the Registration Statement;
	 	(iii)	until the End Date, upon the occurrence of any event contemplated in Section 7(b)(i), except for such times as PubCo is permitted hereunder to suspend, and has suspended, the use of a prospectus forming part of a Registration Statement, PubCo shall use its commercially reasonable efforts to as promptly as reasonably practicable prepare a post-effective amendment to such Registration Statement or a supplement to the related prospectus, or file any other required document so that, as thereafter delivered to purchasers of the Shares included therein, such prospectus will not include any untrue statement of a material fact or omit to state any material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading;
	 	(iv)	until the End Date, use its commercially reasonable efforts to cause all Shares to be listed on each securities exchange or market, if any, on which the PubCo Ordinary Shares issued by PubCo have been listed;
	 	(v)	until the End Date, use its commercially reasonable efforts to take all other steps necessary to effect the registration of the Shares contemplated hereby; and
	 	(vi)	   until the End Date, use its commercially reasonable efforts to remove the legend described in Section 2 (or instruct the Transfer Agent to so remove such legend) from the Shares if (A) the Registration Statement has become effective under the Securities Act, (B) such Shares are sold or transferred pursuant to Rule 144 (if the transferor is not an affiliate of PubCo), or (C) such Shares are eligible for sale under Rule 144, without the requirement for PubCo to be in compliance with the current public information required under Rule 144(c)(1) (or Rule 144(i)(2), if applicable) as to such securities and without volume or manner-of-sale restrictions and without the requirement for PubCo to be in compliance with the current public information required under Rule 144(c)(2) (or Rule 144(i)(2), if applicable); provided that, in each case, the Subscriber agrees to provide PubCo, its counsel and/or the Transfer Agent with evidence reasonably requested by any of PubCo, its counsel and/or the Transfer Agent in order to cause the removal of the legend described in Section 2 (the “Representations”). If a legend is no longer required pursuant to the foregoing, PubCo will, as promptly as practicable following request by the holder, cause the Transfer Agent for the Shares to remove any restrictive legends related to the book entry account holding such Shares and make a new, unlegended entry for such book entry shares sold or disposed of without restrictive legends, subject to the delivery by an applicable holder to PubCo or the Transfer Agent (with notice to PubCo) of a legended certificate or book-entry position representing the Shares (endorsed or with stock powers attached, signatures guaranteed, and otherwise in form necessary to affect the reissuance and/or transfer), if required, and the Representations. Certificates or book-entry positions representing the Shares free from all restrictive legends may be transmitted by the Transfer Agent to the applicable holders by crediting the account of the applicable holder’s prime broker with DTC as directed by such applicable holder. PubCo shall be responsible for the fees of the Transfer Agent, its legal counsel and all DTC fees associated with such issuance.

 

    7 

     

    

 

c.                  
Notwithstanding anything to the contrary in this Subscription Agreement, PubCo shall be entitled to delay or postpone the effectiveness
of the Registration Statement, and from time to time to require any Subscriber not to sell under the Registration Statement or to suspend
the effectiveness thereof, if the negotiation or consummation of a transaction by PubCo or its subsidiaries is pending or an event has
occurred, which negotiation, consummation or event, PubCo’s board of directors reasonably believes, upon the advice of legal counsel,
would require additional disclosure by PubCo in the Registration Statement of material information that PubCo has a bona fide business
purpose for keeping confidential and the non-disclosure of which in the Registration Statement would be expected, in the reasonable determination
of PubCo’s board of directors, upon the advice of legal counsel, to cause the Registration Statement to fail to comply with applicable
disclosure requirements (each such circumstance, a “Suspension Event”); provided, however, that PubCo
may not delay or suspend the effectiveness or use of the Registration Statement on more than two occasions or for more than sixty (60)
consecutive calendar days in any one instance, or more than ninety (90) total calendar days, in each case during any twelve (12)-month
period. Upon receipt of any written notice from PubCo of the happening of any Suspension Event (which notice shall not contain material
non-public information) during the period that the Registration Statement is effective or if as a result of a Suspension Event the Registration
Statement or related prospectus contains any untrue statement of a material fact or omits to state any material fact required to be stated
therein or necessary to make the statements therein, in light of the circumstances under which they were made (in the case of the prospectus)
not misleading, each Subscriber agrees that (i) it will immediately discontinue offers and sales of the Shares under the Registration
Statement (excluding, for the avoidance of doubt, sales conducted pursuant to Rule 144 under the Securities Act) until such Subscriber
receives copies of a supplemental or amended prospectus (which PubCo agrees to promptly prepare) that corrects the misstatement(s) or
omission(s) referred to above and receives notice that any post-effective amendment has become effective or unless otherwise notified
by PubCo that it may resume such offers and sales, and (ii) it will maintain the confidentiality of any information included in such written
notice delivered by PubCo unless otherwise required by law or subpoena. If so directed by PubCo, each Subscriber will deliver to PubCo
or, in such Subscriber’s sole discretion destroy, all copies of the prospectus covering the Shares in such Subscriber’s possession;
provided, however, that this obligation to deliver or destroy all copies of the prospectus covering the Shares shall not
apply (i) to the extent such Subscriber is required to retain a copy of such prospectus (a) in order to comply with applicable legal,
regulatory, self-regulatory or professional requirements or (b) in accordance with a bona fide pre-existing document retention policy
or (ii) to copies stored electronically on archival servers as a result of automatic data back-up. Notwithstanding anything to the contrary
set forth in this Section 7(c), without the prior written approval of the Subscriber, PubCo shall not, when advising the Subscriber
of any of the events set forth in this Section 7(c), provide Subscriber with any material, non-public information regarding PubCo
other than to the extent that providing notice to Subscriber of the occurrence of such events listed above may constitute material, non-public
information regarding PubCo.

 

d.                 
PubCo shall, notwithstanding any termination of this Subscription Agreement, indemnify, defend and hold harmless each Subscriber
(to the extent a seller under the Registration Statement), the officers, directors, employees, advisors and agents of each of them, and
each person who controls such Subscriber (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange
Act) to the fullest extent permitted by applicable law, from and against any and all out-of-pocket losses, claims, damages, liabilities,
costs (including, without limitation, reasonable attorneys’ fees) and expenses (collectively, “Losses”), as incurred,
that arise out of or are based upon (i) any untrue or alleged untrue statement of a material fact contained in the Registration Statement,
any prospectus included in the Registration Statement or any form of prospectus or in any amendment or supplement thereto or in any preliminary
prospectus, or arising out of or relating to any omission or alleged omission to state a material fact required to be stated therein or
necessary to make the statements therein (in the case of any prospectus or form of prospectus or supplement thereto, in light of the circumstances
under which they were made) not misleading, or (ii) any violation or alleged violation by PubCo of the Securities Act, Exchange Act or
any state securities law or any rule or regulation thereunder, in connection with the performance of its obligations under this Section 7,
except to the extent, but only to the extent, that such untrue statements, alleged untrue statements, omissions or alleged omissions are
based upon information regarding such Subscriber furnished in writing to PubCo by such Subscriber expressly for use therein or such Subscriber
has omitted a material fact from such information or otherwise violated the Securities Act, Exchange Act or any state securities law or
any other law, rule or regulation thereunder; provided, however, that the indemnification contained in this Section 7
shall not apply to amounts paid in settlement of any Losses if such settlement is effected without the consent of PubCo (which consent
shall not be unreasonably withheld, conditioned or delayed), nor shall PubCo be liable for any Losses to the extent they arise out of
or are based upon a violation which occurs (A) in reliance upon and in conformity with written information furnished by a Subscriber,
(B) in connection with any failure of such person to deliver or cause to be delivered a prospectus made available by PubCo in a timely
manner, (C) as a result of offers or sales effected by or on behalf of any person by means of a “free writing prospectus”
(as defined in Rule 405 under the Securities Act) that was not authorized in writing by PubCo, or (D) in connection with any offers
or sales effected by or on behalf of a Subscriber in violation of Section 7(c) hereof. PubCo shall notify such Subscriber
promptly of the institution, threat or assertion of any proceeding arising from or in connection with the transactions contemplated by
this Section 7 of which PubCo is aware. Such indemnity shall remain in full force and effect regardless of any investigation
made by or on behalf of an indemnified party and shall survive the transfer of the Shares by such Subscriber.

 

e.                  
Each Subscriber shall, severally and not jointly with any Other Subscriber or any other selling shareholder under the Registration
Statement, indemnify and hold harmless PubCo and each of their directors, officers, agents and employees, and each person who controls
PubCo (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), to the fullest extent permitted
by applicable law, from and against all Losses, as incurred, arising out of or are based upon any untrue or alleged untrue statement of
a material fact contained in any Registration Statement, any prospectus included in the Registration Statement, or any form of prospectus,
or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission
of a material fact required to be stated therein or necessary to make the statements therein (in the case of any prospectus, or any form
of prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading to the extent, but only
to the extent, that such untrue statements or omissions are based upon information regarding such Subscriber furnished in writing to PubCo
by such Subscriber expressly for use therein; provided, however, that the indemnification contained in this Section 7
shall not apply to amounts paid in settlement of any Losses if such settlement is effected without the consent of such Subscriber (which
consent shall not be unreasonably withheld, conditioned or delayed). Notwithstanding anything to the contrary herein, in no event shall
the liability of any Subscriber be greater in amount than the dollar amount of the net proceeds received by such Subscriber upon the sale
of the Shares giving rise to such indemnification obligation. Each Subscriber shall notify PubCo promptly of the institution, threat or
assertion of any proceeding arising from or in connection with the transactions contemplated by this Section 7 of which such
Subscriber is aware. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of an indemnified
party and shall survive the transfer of the Shares by such Subscriber.

 

    8 

     

    

 

f.                   
If the indemnification provided under this Section 7 from the indemnifying party is unavailable or insufficient to hold
harmless an indemnified party in respect of any Losses, then the indemnifying party, in lieu of indemnifying the indemnified party, shall
contribute to the amount paid or payable by the indemnified party as a result of such Losses in such proportion as is appropriate to reflect
the relative fault of the indemnifying party and the indemnified party, as well as any other relevant equitable considerations. The relative
fault of the indemnifying party and indemnified party shall be determined by reference to, among other things, whether any action in question,
including any untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact, was made
by, or relates to information supplied by, such indemnifying party or indemnified party, and the indemnifying party’s and indemnified
party’s relative intent, knowledge, access to information and opportunity to correct or prevent such action. The amount paid or
payable by a party as a result of the Losses shall be deemed to include, subject to the limitations set forth above, any legal or other
fees, charges or expenses reasonably incurred by such party in connection with any investigation or proceeding. No person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution pursuant to this Section
7(f) from any person who was not guilty of such fraudulent misrepresentation. Each indemnifying party’s obligation to make a
contribution pursuant to this Section 7(f) shall be several, not joint. In no event shall the liability of the Subscriber be greater
in amount than the dollar amount of the net proceeds received by the Subscriber upon the sale of the Shares purchased pursuant to this
Subscription Agreement giving rise to such contribution obligation.

 

8.                 
Termination. Except for the provisions of Sections 8, 9, 11 and 12, which shall survive any termination hereunder,
this Subscription Agreement shall terminate and be void and of no further force and effect, and all rights and obligations of the parties
hereunder shall terminate without any further liability on the part of any party in respect thereof, upon the earliest to occur of (a)
such date and time as the Transaction Agreement is terminated in accordance with its terms without the Transaction being consummated,
(b) upon the mutual written agreement of each of the parties hereto to terminate this Subscription Agreement, (c) if any of the conditions
to the Subscription Closing set forth in Section 3 of this Subscription Agreement are not satisfied or waived on or prior
to the Subscription Closing and, as a result thereof, the transactions contemplated by this Subscription Agreement are not consummated
at the Subscription Closing, or (d) if the consummation of the Transaction shall not have occurred by the earlier of (x) the 10th business
day after the anticipated Transaction Closing Date specified in the Closing Notice, or (y) the “Outside Date” as defined in
the Transaction Agreement; provided that, subject to the limitations set forth in Section 9, nothing herein will relieve
any party hereto from liability for any willful breach hereof prior to the time of termination, and each party hereto will be entitled
to any remedies at law or in equity to recover out-of-pocket losses, liabilities or damages arising from such breach. SPAC shall promptly
notify Subscriber of the termination of the Transaction Agreement promptly after the termination of such Transaction Agreement.

 

9.                 
Trust Account Waiver. Subscriber acknowledges that SPAC is a blank check company with the powers and privileges to effect
a merger, asset acquisition, reorganization or similar business combination involving SPAC and one or more businesses or assets. Subscriber
further acknowledges that, as described in SPAC’s prospectus relating to its initial public offering dated February 19, 2020 available
at www.sec.gov, substantially all of SPAC’s assets consist of the cash proceeds of SPAC’s initial public offering and private
placements of its securities, and substantially all of those proceeds have been deposited in a trust account (the “Trust Account”)
for the benefit of SPAC, its public stockholders and the underwriters of SPAC’s initial public offering. For and in consideration
of SPAC entering into this Subscription Agreement, the receipt and sufficiency of which are hereby acknowledged, Subscriber hereby irrevocably
waives any and all right, title and interest, or any claim of any kind it has or may have in the future, in or to any monies held in or
distributions from the Trust Account, and agrees not to seek recourse against the Trust Account, in each case, as a result of, or arising
out of, this Subscription Agreement; provided that nothing in this Section 9 shall be deemed to limit Subscriber’s
right, title, interest or claim to the Trust Account by virtue of Subscriber’s record or beneficial ownership of shares of SPAC
Common Stock that have or will be acquired outside of this Agreement.

 

10.             
Cleansing Statement; Disclosure.

 

a.                  
SPAC shall, no later than 9:00 a.m., New York City time, on the first (1st) business day immediately following the date of this
Subscription Agreement, issue one or more press releases or file with the SEC a Current Report on Form 8-K (collectively, the “Disclosure
Document”) disclosing all material terms of the transactions contemplated hereby, the Transaction and any other material, nonpublic
information that SPAC has provided to Subscriber at any time prior to the filing of the Disclosure Document. From and after the issuance
of the Disclosure Document, to the knowledge of SPAC, Subscriber shall not be in possession of any material, non-public information received
from SPAC or any of its officers, directors, employees or agents.

 

b.                 
Notwithstanding anything in this Subscription Agreement to the contrary, each party hereto acknowledges and agrees that, without
the prior written consent of the other party hereto, it will not publicly make reference to such other party or any of its affiliates
(i) in connection with the Transaction or this Subscription Agreement (provided that Subscriber may disclose its entry into this
Subscription Agreement and the Purchase Price) or (ii) in any promotional materials, media, press releases or similar circumstances, except,
in each case, as required by law or regulation or at the request of the Staff of the SEC or regulatory agency or under the regulations
of Nasdaq or the NYSE, including, in the case of SPAC or PubCo, (a) as required by the federal securities laws in connection with the
Registration Statement, (b) the filing of this Subscription Agreement (or a form of this Subscription Agreement) with the SEC, (c) the
filing of the Registration Statement on Form F-4 and Schedule 14A and related materials to be filed by PubCo and SPAC with respect
to the Transaction, and (d) the filing of listing applications and related materials to by filed by PubCo and SPAC to Nasdaq in connection
with the Transaction or this Subscription Agreement; provided that PubCo and/or SPAC, as applicable, shall use commercially reasonable
efforts to provide Subscriber with two (2) business days’ prior written notice of any such required public reference except those
required public references made under subclauses (a), (b), (c) or (d), and provided further that Subscriber agrees to promptly provide
any information that may be reasonably requested by PubCo or SPAC in connection with filings to be made pursuant to subclauses (a), (b),
(c) or (d).

 

    9 

     

    

 

11.       
Non-Reliance. Subscriber acknowledges that it is not relying upon, and has not relied upon, any statement, representation
or warranty made by any person, firm or corporation, other than the representations and warranties of PubCo and SPAC expressly set forth
in this Subscription Agreement or in the SEC Documents, in making its investment or decision to invest in PubCo. Subscriber agrees that
no Other Subscriber pursuant to the Other Subscription Agreements or any other agreement related to the private placement of shares of
PubCo’s capital stock (including the controlling persons, officers, directors, partners, agents or employees of any such Other Subscriber)
shall be liable to any Other Subscriber pursuant to the Other Subscription Agreements or any other agreement related to the private placement
of shares of PubCo’s capital stock for any action heretofore or hereafter taken or omitted to be taken by any of them in connection
with the purchase of PubCo Ordinary Shares.

 

12.             
Miscellaneous.

 

a.                  
Subscriber agrees that, from the date of this Subscription Agreement until the Subscription Closing or earlier termination of this
Subscription Agreement, none of Subscriber or any person or entity acting on behalf of Subscriber or pursuant to any understanding with
Subscriber will engage in any hedging or other transactions or arrangements (including, without limitation, any short sale or the purchase
or sale of, or entry into, any put or call option, or combination thereof, forward, swap or any other derivative transaction or instrument,
however described or defined) designed or intended, or which could reasonably be expected to lead to or result in, a sale, loan, pledge
or other disposition or transfer (whether by Subscriber or any other person) of any economic consequences of ownership, in whole or in
part, directly or indirectly, of any securities of SPAC, whether any such transaction or arrangement (or instrument provided for thereunder)
would be settled by delivery of securities of SPAC, in cash or otherwise, or to publicly disclose the intention to undertake any of the
foregoing; provided, however, that for purposes of this Section 12(a) only, reference to “short sale” shall not include
any short sale, options, puts, calls, hedging or similar arrangements if, at any point during the day the short sale, option, put,
call or similar arrangement is entered into, the stock price for the SPAC common shares is at or above $15 per share (which shall be permitted);
provided further that the provisions of this Section 12(a) shall not apply to long sales (including sales of securities held by
Subscriber prior to the date of this Subscription Agreement and securities purchased by Subscriber in the open market after the date of
this Subscription Agreement). Notwithstanding the foregoing, nothing in this Section 12(a) (i) shall prohibit any entities under
common management with Subscriber that have no knowledge of this Subscription Agreement or of Subscriber’s participation in the
transactions contemplated hereby from entering into any such transactions; and (ii) in the case of a Subscriber that is a multi-managed
investment vehicle whereby separate portfolio managers manage separate portions of Subscriber’s assets and the portfolio managers
have no knowledge of the investment decisions made by the portfolio managers managing other portions of Subscriber’s assets, this
Section 12(b) shall only apply with respect to the portion of assets managed by the portfolio managers who have knowledge of this
Subscription Agreement or of Subscriber’s participation in the transactions contemplated hereby.

 

b.                 
Neither this Subscription Agreement nor any rights that may accrue any party hereunder (other than the Shares acquired hereunder,
if any) may be transferred or assigned; provided that prior to the Subscription Closing, Subscriber may transfer or assign all
or a portion of its rights or obligations under this Subscription Agreement to one or more affiliates (including other investment funds
or accounts managed or advised by an investment manager who acts on behalf of Subscriber); provided, further, that, such transferee or
assignee agrees in writing to be bound by and subject to the terms and conditions of this Subscription Agreement, makes the representations
and warranties in Section 6 and completes Schedule A hereto; provided, further, that no such assignment will relieve Subscriber of its
obligations hereunder if any such assignee fails to perform such obligations.

 

c.                  
SPAC and PubCo may request from Subscriber such additional information as SPAC and PubCo may reasonably determine necessary to
evaluate the eligibility of Subscriber to acquire the Shares, and Subscriber shall provide such information as may reasonably be requested,
to the extent readily available and to the extent consistent with its internal policies and procedures; provided that SPAC agrees to keep
confidential any such information provided by Subscriber and identified as confidential, except as may be required under applicable law.

 

d.                 
Each party acknowledges that the other parties hereto will rely on the acknowledgments, understandings, agreements, representations
and warranties contained in this Subscription Agreement. Prior to the Subscription Closing, each party hereto agrees to promptly notify
the other party hereto if any of the acknowledgments, understandings, agreements, representations and warranties of such party set forth
herein are no longer accurate in all material respects. Each party agrees that the purchase by Subscriber of Shares from PubCo will constitute
a reaffirmation of its own acknowledgments, understandings, agreements, representations and warranties herein (as modified by any such
notice) as of the Subscription Closing.

 

e.                  
SPAC and PubCo are entitled to rely upon this Subscription Agreement and SPAC and PubCo are each irrevocably authorized to produce
this Subscription Agreement or a copy hereof when required by law, regulatory authority or Nasdaq or the NYSE to do so in any administrative
or legal proceeding or official inquiry with respect to the matters covered hereby.

 

f.                   
Subject to Section 10 hereof, and except if required by law or Nasdaq or the NYSE, without the prior written consent of
Subscriber, SPAC shall not, and shall cause its representatives, not to, disclose the existence of this Subscription Agreement or any
negotiations related hereto, or to use the name of Subscriber or any information provided by Subscriber in connection herewith in or for
the purpose of any marketing activities or materials or for any similar or related purpose.

 

g.                 
All the agreements, representations and warranties made by each party hereto in this Subscription Agreement shall survive the Subscription
Closing.

 

    10 

     

    

 

h.                 
This Subscription Agreement may not be amended, supplemented, modified, waived or terminated except by an instrument in writing,
signed by the party against whom enforcement of such amendment, modification, waiver, or termination is sought, except that prior to the
Subscription Closing, SPAC may sign an instrument amending, supplementing, modifying or waiving this Subscription Agreement for and on
behalf of PubCo.

 

i.                   
This Subscription Agreement constitutes the entire agreement, and supersedes all other prior agreements, understandings, representations
and warranties, both written and oral, among the parties, with respect to the subject matter hereof. Except as otherwise expressly set
forth herein, this Subscription Agreement shall not confer any rights or remedies upon any person other than the parties hereto, and their
respective successor and assigns.

 

j.                   
Except as otherwise provided herein, this Subscription Agreement shall be binding upon, and inure to the benefit of the parties
hereto and their heirs, executors, administrators, successors, legal representatives, and permitted assigns, and the agreements, representations,
warranties, covenants and acknowledgments contained herein shall be deemed to be made by, and be binding upon, such heirs, executors,
administrators, successors, legal representatives and permitted assigns.

 

k.                 
 If any provision of this Subscription Agreement shall be invalid, illegal or unenforceable, the validity, legality or enforceability
of the remaining provisions of this Subscription Agreement shall not in any way be affected or impaired thereby and shall continue in
full force and effect.

 

l.                   
This Subscription Agreement may be executed in one or more counterparts (including by facsimile or electronic mail or in .pdf or
any other form of electronic delivery, including DocuSign) and by different parties in separate counterparts, with the same effect as
if all parties hereto had signed the same document. All counterparts so executed and delivered shall be construed together and shall constitute
one and the same agreement.

 

m.               
Subscriber shall pay all of its own expenses in connection with this Subscription Agreement and the transactions contemplated herein.

 

n.                 
Any notice or communication required or permitted hereunder shall be in writing and either delivered personally, emailed or telecopied,
sent by overnight mail via a reputable overnight carrier, or sent by certified or registered mail, postage prepaid, and shall be deemed
to be given and received (a) when so delivered personally, (b) upon receipt of an appropriate electronic answerback or confirmation
when so delivered by telecopy (to such number specified below or another number or numbers as such person may subsequently designate by
notice given hereunder), (c) when sent, with no mail undeliverable or other rejection notice, if sent by email, or (d) two (2) business
days after the date of mailing to the address below or to such other address or addresses as such person may hereafter designate by notice
given hereunder:

 

	 	(i)	if to Subscriber, to such address, facsimile number or email address set forth on the signature page hereto;

	 	(ii)	if to SPAC (prior to the Transaction Closing), to:

 

East Stone Acquisition Corp.

25 Mall Road, Suite 330

Burlington, MA 01803

Attn: Sherman Xiaoma Lu, Chief Executive
Officer

Telephone No.: 781 202 9128

Email: sherman@estonecapital.com

 

with a copy (which will not constitute notice) to:

Ellenoff Grossman & Schole LLP

1345 Avenue of the Americas, 11th Floor

New York, New York 10105, USA

Attn: Barry I. Grossman, Esq.

Facsimile No.: (212) 370-7889

Telephone No.: (212) 370-1300

Email: bigrossman@egsllp.com

 

    11 

     

    

  

	 	(iii)	if to PubCo (prior to the Transaction Closing), to:

 

NWTN Inc.

No.76 Mu Nan Road, Heping District, Tianjin, China

Attention: Jinbao Su

Email: ir@iconiqmotors.com

 

with a copy (which will not constitute notice) to:

 

Linklaters LLP

1290 Avenue of the Americas

New York, NY 10104

Facsimile No.: +1 212 903 9100

Phone No.: +1 212-903-9000

 

and a copy to:

 

Linklaters LLP

11th Floor, Alexandra House

Chater Road

Hong Kong SAR

Facsimile No.: +852 2810 8133

Phone No.: +852 2810 8133

 

	 	(iv)	if to SPAC or PubCo (following the Transaction Closing), to:

 

NWTN Inc.

No.76 Mu Nan Road, Heping District, Tianjin, China

Attention: Jinbao Su

Email: ir@iconiqmotors.com

 

with a copy (which will not constitute notice) to:

 

Linklaters LLP

1290 Avenue of the Americas

New York, NY 10104

Facsimile No.: +1 212 903 9100

Phone No.: +1 212-903-9000

 

and a copy to:

 

Linklaters LLP

11th Floor, Alexandra House

Chater Road

Hong Kong SAR

Facsimile No.: +852 2810 8133

Phone No.: +852 2810 8133

 

    12 

     

    

 

o.                 
The parties hereto agree that irreparable damage would occur in the event that any of the provisions of this Subscription Agreement
were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the parties shall
be entitled to an injunction or injunctions to prevent breaches of this Subscription Agreement and to enforce specifically the terms and
provisions of this Subscription Agreement, this being in addition to any other remedy to which such party is entitled at law, in equity,
in contract, in tort or otherwise.

 

p.                 
This Subscription Agreement, and any claim or cause of action hereunder based upon, arising out of or related to this Subscription
Agreement (whether based on law, in equity, in contract, in tort or any other theory) or the negotiation, execution, performance or enforcement
of this Subscription Agreement, shall be governed by and construed in accordance with the laws of the State of Delaware, without giving
effect to the principles of conflicts of law thereof.

 

q.                 
Each of the parties irrevocably consents to the exclusive jurisdiction and venue of the Court of Chancery of the State of Delaware,
provided that if subject matter jurisdiction over the matter that is the subject of the legal proceeding is vested exclusively in the
U.S. federal courts, such legal proceeding shall be heard in the U.S. District Court for the District of Delaware (together with the Court
of Chancery of the State of Delaware, “Chosen Courts”), in connection with any matter based upon or arising out of
this Subscription Agreement. Each party hereby waives, and shall not assert as a defense in any legal dispute, that (i) such person is
not personally subject to the jurisdiction of the Chosen Courts for any reason, (ii) such legal proceeding may not be brought or is not
maintainable in the Chosen Courts, (iii) such person’s property is exempt or immune from execution, (iv) such legal proceeding is
brought in an inconvenient forum or (v) the venue of such legal proceeding is improper. Each party hereby consents to service of process
in any such proceeding in any manner permitted by Delaware law, further consents to service of process by nationally recognized overnight
courier service guaranteeing overnight delivery, or by registered or certified mail, return receipt requested, at its address specified
pursuant to Section 12(o) and waives and covenants not to assert or plead any objection which they might otherwise have to such
manner of service of process. Notwithstanding the foregoing in this Section 12(r), a party may commence any action, claim, cause
of action or suit in a court other than the Chosen Courts solely for the purpose of enforcing an order or judgment issued by the Chosen
Courts. TO THE EXTENT NOT PROHIBITED BY APPLICABLE LAW WHICH CANNOT BE WAIVED, EACH OF THE PARTIES WAIVES ANY RIGHT TO TRIAL BY JURY ON
ANY CLAIMS OR COUNTERCLAIMS ASSERTED IN ANY LEGAL DISPUTE RELATING TO THIS SUBSCRIPTION AGREEMENT WHETHER NOW EXISTING OR HEREAFTER ARISING.
IF THE SUBJECT MATTER OF ANY SUCH LEGAL DISPUTE IS ONE IN WHICH THE WAIVER OF JURY TRIAL IS PROHIBITED, NO PARTY SHALL ASSERT IN SUCH
LEGAL DISPUTE A NONCOMPULSORY COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS SUBSCRIPTION AGREEMENT. FURTHERMORE, NO PARTY SHALL SEEK
TO CONSOLIDATE ANY SUCH LEGAL DISPUTE WITH A SEPARATE ACTION OR OTHER LEGAL PROCEEDING IN WHICH A JURY TRIAL CANNOT BE WAIVED.

 

r.                   
The obligations of each Subscriber under this Subscription Agreement are several and not joint with the obligations of any Other
Subscriber under the Other Subscription Agreements, and no Subscriber shall be responsible in any way for the performance of the obligations
of any Other Subscriber under this Subscription Agreement. The decision of Subscriber to purchase the Shares pursuant to this Subscription
Agreement has been made by Subscriber independently of any Other Subscriber or any other investor and independently of any information,
materials, statements or opinions as to the business, affairs, operations, assets, properties, liabilities, results of operations, condition
(financial or otherwise) or prospects of PubCo which may have been made or given by any Other Subscriber or by any agent or employee of
any Other Subscriber, and neither Subscriber nor any of its agents or employees shall have any liability to any Other Subscriber (or any
other person) relating to or arising from any such information, materials, statements or opinions. Nothing contained herein or in any
Other Subscription Agreement, and no action taken by Subscriber or any Subscriber pursuant hereto, shall be deemed to constitute any Subscriber
or any Other Subscribers under the Other Subscription Agreements as a partnership, an association, a joint venture or any other kind of
entity, or create a presumption that any Subscribers are in any way acting in concert or as a group with respect to such obligations or
the transactions contemplated by the this Subscription Agreement and the Other Subscription Agreements; provided that it is acknowledged
that certain Subscribers may be under common management with an Other Subscriber. Each Subscriber acknowledges that no Other Subscriber
has acted as agent for Subscriber in connection with making its investment hereunder and no Other Subscriber will be acting as agent of
Subscriber in connection with monitoring its investment in the Shares or enforcing its rights under this Subscription Agreement. Each
Subscriber shall be entitled to independently protect and enforce its rights, including without limitation the rights arising out of this
Subscription Agreement, and it shall not be necessary for any Other Subscriber to be joined as an additional party in any proceeding for
such purpose.

 

13.             
Massachusetts Business Trust. If Subscriber is a Massachusetts Business Trust, a copy of the Agreement and Declaration of
Trust of Subscriber or any affiliate thereof is on file with the Secretary of State of the Commonwealth of Massachusetts and notice is
hereby given that the Subscription Agreement is executed on behalf of the trustees of Subscriber or any affiliate thereof as trustees
and not individually and that the obligations of the Subscription Agreement are not binding on any of the trustees, officers or stockholders
of Subscriber or any affiliate thereof individually but are binding only upon Subscriber or any affiliate thereof and its assets and property.

 

    13 

     

    

 

IN WITNESS WHEREOF,
the undersigned has executed or caused this Subscription Agreement to be executed by its duly authorized representative as of the date
set forth below.

 

	Name of Subscriber: 	 	State/Country of Formation or Domicile:

 

	 	 	 
	By:	 	 	 
	 	 	 	 
	Name:	 	 	 
	 	 	 	 
	Title:	 	 	 

 

	Name in which shares are to be registered (if different):	 	Date: _______________, 2022
	 	 	 
	Subscriber’s EIN:	 	 
	 	 	 
	Business Address-Street:	 	Mailing Address-Street (if different):
	 	 	 
	City, State, Zip:	 	City, State, Zip:
	 	 	 
	Attn:__________________	 	Attn:__________________
	 	 	 
	Telephone No.:	 	Telephone No.:
	 	 	 
	Facsimile No.:	 	Facsimile No.:
	 	 	 
	Email Address:	 	Email Address:
	 	 	 
	Number of Shares subscribed for: (assuming that the Per Share Price is $_______)	 	 
	 	 	 
	Purchase Price: 	 	Price Per Share: $_______ or if lower, the Redemption Price

 

You must pay the Purchase
Price by wire transfer of United States dollars in immediately available funds to the account specified by SPAC and PubCo in the Closing
Notice.

 

    14 

     

    

 

IN WITNESS WHEREOF,
SPAC and PubCo have accepted this Subscription Agreement as of the date set forth below.

 

	 	East Stone Acquisition Corporation
	 	 	 
	 	By:	 
	 	Name:	Xiaoma (Sherman) Lu
	 	Title:	Chief Executive Officer
	Date: August 12, 2022	 	 
	 	 	 
	 	 	 
	 	NWTN Inc.
	 	 	 
	 	By:	 
	 	Name:	Nan Wu
	 	Title:	Director
	Date: August 12, 2022	 	 

 

    15 

     

    

 

SCHEDULE A

ELIGIBILITY REPRESENTATIONS OF SUBSCRIBER

 

A.       QUALIFIED INSTITUTIONAL
BUYER STATUS

 

(Please check the applicable subparagraphs):

 

		1.	☐ We are a “qualified institutional buyer” (as defined
in Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”) (a “QIB”)).

 

		2.	☐ We are subscribing for the Shares as a fiduciary or agent
for one or more investor accounts, and each owner of such account is a QIB.

 

*** OR ***

 

		B.	INSTITUTIONAL ACCREDITED INVESTOR STATUS (Please check the box if applicable):

 

☐
We are an “accredited investor” (within the meaning of Rule 501(a)(1), (2), (3) or (7) under the Securities Act) and have
marked and initialed the appropriate box below indicating the provision under which we qualify as an institutional “accredited investor.”

 

*** AND ***

 

C.       AFFILIATE STATUS

(Please check the applicable box) SUBSCRIBER:

☐is:

☐is
not:

an “affiliate” (as defined in Rule 144 under the
Securities Act) of PubCo or acting on behalf of an affiliate of PubCo.

 

This page should be completed by
Subscriber

and constitutes a part of the Subscription Agreement.

 

    16 

     

    

 

Rule 501(a) under the Securities Act, in relevant part, states that
an institutional “accredited investor” shall mean any person who comes within any of the below listed categories, or who the
issuer reasonably believes comes within any of the below listed categories, at the time of the sale of the securities to that person.
Subscriber has indicated, by marking and initialing the appropriate box below, the provision(s) below which apply to Subscriber and under
which Subscriber accordingly qualifies as an institutional “accredited investor.”

 

		☐	Any bank as defined in section 3(a)(2) of the Securities Act, or any savings and loan association or other institution as defined
in section 3(a)(5)(A) of the Securities Act whether acting in its individual or fiduciary capacity;

		☐	Any broker or dealer registered pursuant to section 15 of the Securities Exchange Act of 1934, as amended;

		☐	Any insurance company as defined in section 2(a)(13) of the Securities Act;

		☐	Any investment company registered under the Investment Company Act of 1940, as amended (the “Investment Company Act”)
or a business development company as defined in section 2(a)(48) of the Investment Company Act;

		☐	Any Small Business Investment Company licensed by the U.S. Small Business Administration under section 301(c) or (d) of the Small
Business Investment Act of 1958, as amended;

		☐	Any plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its political
subdivisions, for the benefit of its employees, if such plan has total assets in excess of $5,000,000;

		☐	Any employee benefit plan within the meaning of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”),
if (i) the investment decision is made by a plan fiduciary, as defined in section 3(21) of ERISA, which is either a bank, a savings and
loan association, an insurance company, or a registered investment adviser or (ii) the employee benefit plan has total assets in excess
of $5,000,000;

		☐	Any private business development company as defined in section 202(a)(22) of the Investment Advisers Act of 1940, as amended;

		☐	Any (i) corporation, limited liability company or partnership, (ii) Massachusetts or similar business trust, or (iii) organization
described in section 501(c)(3) of the Internal Revenue Code of 1986, as amended, not formed for the specific purpose of acquiring the
securities offered, and with total assets in excess of $5,000,000; or

		☐	Any trust, with total assets in excess of $5,000,000, not formed for the specific purpose of acquiring the securities offered, whose
purchase is directed by a sophisticated person as described in Section 230.506(b)(2)(ii) of Regulation D.

 

 

    17

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00347-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00347-of-00352.parquet"}]]